PentaBase is a knowledge-based Danish pharmacogenomics company founded and managed by researchers and located in the heart of Denmark. We specialize in custom oligonucleotide production and development of in vitro diagnostic assays for real-time PCR with special focus on detection of somatic mutations in cancer. For more than 10 years, PentaBase has created products for researchers and medical professionals exploring new treatments and helping patients worldwide.
Our products are based on our proprietary technology, Intercalating Nucleic Acids (INAs®), giving our products unique abilities in analysis and manipulation of genetic material. These features are used by medical professionals and researchers to help treat diseases and acquire new knowledge. We believe in open-platform designs and strive to make our products compatible with basic instruments used in molecular biology facilities around the world.
Our visions are:
■ To enable detection and monitoring of treatable diseases as early and as efficiently as possible.
■ To broaden and improve the use of personalized treatment of genetic diseases and cancer
■ To reduce the number of false negative samples by improving sensitivity and reducing complexity of genetic analyses
We are continuously working with researchers and the research community to develop new products, and are always open for new collaborations. If you have a challenge in genetic analysis, then talk to us.